戴納基 DYN 深滬

等待開盤 11-17 09:30:00 美东时间

18.79

-0.040

-0.21%

華盛通

立即下載

最高19.41
今開18.34
成交量 189.61万股
最低 18.34
昨收 18.83
總市值 26.68亿
52周最高 31.32
市盈率 ^靜 --
換手率 1.34%
52周最低 6.36
委比 -14.90%
總股本 1.42亿
歷史最高 47.45
量比 0.85
振幅 5.68%
歷史最低 4.30
每手 1
風險率 6.03%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

美股大行评级 | 花旗上调Bilibili目标价升至27美元；摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级

花旗上调Bilibili目标价升至27美元；摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>

今天 10:49
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元

今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元

11-13 09:58
Oppenheimer Maintains Perform on Dyne Therapeutics, Lowers Price Target to $11

Oppenheimer analyst Andreas Argyrides maintains Dyne Therapeutics (NASDAQ:DYN) with a Perform and lowers the price target from $13 to $11.

11-13 00:16
美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价

高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价

11-07 10:14
Dyne Therapeutics Q3 EPS $(0.76) Beats $(0.85) Estimate

Dyne Therapeutics (NASDAQ:DYN) reported quarterly losses of $(0.76) per share which beat the analyst consensus estimate of $(0.85) by 11.01 percent. This is a 20.83 percent increase over losses of $(0.96) per share from

11-06 06:08
Dyne Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Dyne Therapeutics的两个药物DYNE-251（用于治疗杜兴氏肌肉营养不良症）和DYNE-101（用于治疗第一型肌强直性营养不良症）均获美国FDA授予突破性疗法认定。双方均取得积极临床进展，预计将于2025年12月和2026年第一季度分别提交BLA申请，并有望在2027年初实现商业化。Dyne公司现金储备充足，预计可支持至2027年第三季度的运营需求。

11-05 21:10
Active ETFs: The Party Everyone's Invited To, But Few Can Dance At

Active ETFs are booming in 2025, but few break through as distribution hurdles sideline many newcomers.

11-05 04:03
Dyne Therapeutics to Present at Upcoming Investor Conferences

Dyne Therapeutics announced that its management will present at four upcoming investor conferences in November and December 2025. The presentations will include fireside chats at the Guggenheim 2nd Annual Healthcare Innovation Conference, Stifel 2025 Healthcare Conference, Jefferies Global Healthcare Conference, and the 8th Annual Evercore Healthcare Conference. Live webcasts will be available on Dyne’s website, and replays will be accessible for...

11-03 12:30
Dynagas LNG Partners LP Announces the Date of Its 2025 Annual Meeting of Limited Partners

Dynagas LNG Partners LP has announced the 2025 Annual Meeting of Limited Partners will be held on November 26, 2025, at 4:00 p.m. local time in Athens, Greece. The record date for determining eligible Limited Partners is October 27, 2025. The Meeting Notice and Proxy Statement will be mailed on October 29, 2025, and published on the SEC website (www.sec.gov) and the company’s website (www.dynagaspartners.com).

10-29 20:55
美股牛股 | 阿根廷总统米莱选举大胜引爆行情！阿根廷概念股全线飙升；生物制药公司RNA大涨42.4%

阿根廷总统米莱选举大胜引爆行情！阿根廷概念股全线飙升，SUPV涨48%、BBAR涨超40%；生物制药公司RNA大涨42.4%>>

10-28 11:27

派息除權日	每股總股息	派息日期
2002-05-30	0.08	2002-06-17
2002-02-27	0.08	2002-03-15
2001-11-29	0.08	2001-12-17
2001-08-29	0.08	2001-09-17
2001-05-29	0.08	2001-06-15
2001-02-27	0.08	2001-03-15
2000-11-29	0.08	2000-12-15
2000-08-29	0.08	2000-09-15
2000-05-26	0.15	2000-06-15
2000-02-24	0.04	2000-03-31
1999-12-01	0.01	1999-12-21
1999-09-01	0.01	1999-09-21
1999-06-01	0.01	1999-06-28
1999-03-04	0.01	1999-03-26
1998-12-01	0.01	1998-12-21
1998-09-01	0.01	1998-09-21
1998-05-28	0.01	1998-06-22
1998-03-09	0.01	1998-03-27
1997-12-01	0.01	1997-12-19
1997-08-22	0.01	1997-09-16
1997-05-21	0.01	1997-06-16
1997-02-13	0.01	1997-03-05
1996-11-27	0.01	1996-12-16
1996-07-25	0.01	1996-09-03
1996-05-16	0.01	1996-06-04
1996-03-21	0.01	1996-04-09
1995-12-14	0.01	1996-01-02
1995-09-21	0.01	1995-10-10
1995-06-16	0.01	1995-07-05
1995-03-01	0.01	1995-03-21
1994-12-01	0.01	1994-12-21
1994-08-31	0.01	1994-09-21
1994-06-01	0.01	1994-06-21
1994-03-01	0.01	1994-03-21
1984-10-03	0.66	1984-11-01
1984-07-03	0.66	1984-08-01
1984-04-04	0.66	1984-05-01
1984-01-04	0.66	1984-02-01
1983-10-03	0.62	1983-11-01
1983-07-05	0.62	1983-08-01
1983-04-05	0.62	1983-05-02
1983-01-04	0.62	1983-02-01
1982-10-04	0.62	1982-11-01
1982-07-02	0.62	1982-08-02
1982-04-02	0.62	1982-05-01
1982-01-05	0.62	1982-02-01
1981-10-05	0.60	1981-11-02
1981-07-06	0.60	1981-08-01
1981-04-06	0.60	1981-05-01
1981-01-05	0.60	1981-02-02
1980-10-06	0.60	1980-11-01
1980-07-03	0.60	1980-08-01
1980-04-02	0.57	1980-05-01
1980-01-03	0.57	1980-01-31
1979-10-02	0.57	1979-10-31
1979-07-02	0.57	1979-07-31
1979-04-03	0.57	1979-04-30
1979-01-03	0.57	1979-01-31
1978-10-02	0.57	1978-10-31
1978-07-02	0.57	1978-07-31
1978-04-03	0.57	1978-04-30
1978-01-03	0.57	1978-01-31
1977-10-02	0.55	1977-10-31
1977-06-30	0.55	1977-07-31
1977-04-03	0.55	1977-05-01

公司名稱	戴纳基
行業分類	电力
業務描述	Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.

戴納基 DYN 深 滬

18.79

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

戴納基 DYN 深滬